DeGen Medical has filed a motion to dismiss key parts of a patent infringement lawsuit from Carlsmed, which claims DeGen's patient-specific spinal implants infringe on eight patents. DeGen argues that the contested patents cover abstract, computer-implemented methods that are not patent-eligible, contrasting with DeGen's human-collaborative implant design approach. The company also seeks dismissal of willfulness claims and unsupported infringement theories. DeGen vows to defend its approach and continue serving patients without disruption.
DeGen Medical's patent dispute is the focus here, with Pluang's health sector showing mixed activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 16, 2026 03:11 WIB: out of 150 priced US health-sector stocks, 71 rose and 77 fell. Notable movers include Summit Therapeutics Inc (SMMT) at USD 14.15, down 6.14%, Ginkgo Bioworks Holdings Inc (DNA) at USD 9.61, down 6.06%, and Aveanna Healthcare Holdings Inc (AVAH) at USD 11.50, down 6.05%.
SoFi announced it expects about 50% growth in earnings for 2027, signaling strong financial performance ahead. The company also stated it will not need to raise new capital, indicating confidence in its current funding and business model. This outloo...
Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as...
A new cyberattack using AI assistance has targeted Bitcoin mining infrastructure amid a recent price decline. Luxor's CEO revealed the sophisticated nature of the attack and announced plans to review the incident and apologize to affected customers. ...
Meteora AG has introduced DLMM Pro in beta on the Solana blockchain, offering token creators new tools to customize liquidity and fees. The platform integrates Meteora’s Dynamic Liquidity Market Maker, DAMM V2, and Dynamic Bonding Curve technologies,...
Arbitrum One, an Ethereum layer-2 network, generated over $400,000 in priority-fee revenue this week while transactions across Arbitrum surpassed 35 million. The network aims to speed up transactions and reduce fees on Ethereum. Additionally, Arbitru...
